Educational Tools

Biosimilars

• Biosimilars - What IBD Patients Should Know
• Biosimilar Patient and Prescriber Outreach Materials
• Biosimilar Development, Review, and Approval

Cirrhosis

• Hepatic Encephalopathy in Chronic Liver Disease
• Cirrhosis
• Hepatic Encephalopathy

Hepatitis C Virus (HCV)

• HCV Next
• American Gastroenterological Association Hepatitis C Resources
• CDC’s Testing Recommendations for Hepatitis C Infection
• HCV Infection Testing Algorithm
• Interpretation of HCV Testing Results and Further Actions
• Patient-reported outcomes in chronic hepatitis C
• Revolutionizing Treatment Outcomes in Hepatitis C: Managed Care Implications and Considerations
• Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations From the Department of Veterans Affairs
• Direct-Acting Antivirals: Side Effects Management Handouts
• Liver Transplantation Journal

Hepatitis B Virus (HBV)

• Serologic Test Results
• Testing Asian Americans and Pacific Islanders
• Hepatitis B Are You At Risk - Patient Handout

Inflammatory Bowel Disease

• Emotional Well-being Questionnaire – A Patient/Provider Communication Aid
• ACG Clinical Guideline: Ulcerative Colitis in Adults
• Which IBD Medication is Right for Me?
• Tofacitinib Prescribing Information
• Vedolizumab Prescribing Information
• Quality indicators for colonoscopy
• IBD Checklist for Monitoring & Prevention
• IBD Checklist for Care Continuity
• Ostomates Food Reference Chart
• Ostomy Resources
• Inflammatory Crohn’s Disease: Thiopurines, Methotrexate and Anti-TNF-Alpha Biologic Drugs for Induction and Maintenance of Remission
• Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
• Patient Handout: Types of Medications for Crohn's Disease and Ulcerative Colitis
• IBD Surveys/Questionnaires for Clinical Practice
• Ulcerative Colitis Care Pathway
• Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)
• IBD Fact Book
• Signs, Symptoms and Causes of Ulcerative Colitis
• Understanding Ulcerative Colitis - Patient Handout
• Questions to ask your Doctor - Patient Handout

Lysosomal Acid Lipase Deficiency (LAL-D)

• LAL-D: An under-recognized cause of dyslipidaemia and liver dysfunction
• LAL-D: Getting Tested

Non-Alcoholic Fatty Liver Disease (NAFLD)

• Diagnosis and Management of Non-alcoholic Fatty Liver Disease
• From NAFLD in Clinical Practice to Answers From Guidelines
• NAFLD: Differential Diagnosis – Summary
• NAFLD: Overview of Screening Methods in Children